Skip to main content

Implementation of tuberculosis infection control measures at HIV care and treatment sites in sub-Saharan Africa

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: A total of 663 human immunodeficiency virus (HIV) care and treatment sites in nine tuberculosis (TB) affected African countries, serving over 900 000 persons living with HIV.

OBJECTIVE: To determine the implementation of infection control (IC) measures and whether program and facility characteristics were associated with implementation of these measures.

DESIGN: A survey was conducted to assess the presence of a TB IC plan, triage practices for TB suspects, location of sputum collection and availability of particulate respirators. The association of facility characteristics with IC measures was examined using bivariate and multivariate methods.

RESULTS: Forty-seven per cent (range across countries [RAC] 2–77%) of sites had written TB IC plans; 60% (RAC 5–93%) practiced triage; of those with access to microscopy, 83% (RAC 59–91%) performed sputum collection outdoors and 13% (RAC 0–36%) in ventilated indoor rooms; 16% (RAC 1–87%) had particulate respirators available. Sites providing anti-tuberculosis treatment were more likely to have written IC plans (54% vs. 12%, P < 0.0001) and particulate respirators (18% vs. 8%, P = 0.0126), and to perform TB triage (65% vs. 40%, P = 0.0001) than those without anti-tuberculosis treatment services.

CONCLUSIONS: To protect HIV-infected patients and health care workers, there is an urgent need to scale up IC practices at HIV care and treatment sites, particularly at sites without anti-tuberculosis treatment services.

Keywords: HIV; infection control; tuberculosis

Document Type: Research Article

Affiliations: 1: Botswana–University of Pennsylvania Partnership, University of Pennsylvania, Philadelphia, Pennsylvania, USA 2: International Center for AIDS Care and Treatment Programs, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA 3: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA; City University of New York School of Public Health, New York, New York, USA 4: International Center for AIDS Care and Treatment Programs, Mailman School of Public Health, Columbia University, New York, New York, USA

Publication date: 01 December 2012

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content